source
- Trump’s MMR order; LSD drug clears Phase 3 test; and moreWelcome back to another edition of Endpoints Weekly! We’re in the dog days of summer, but we still have some big stories to recap for you this weekend. Let’s break it down. Despite keeping Robert ...Endpoints · 34m ago↗ source
- EU regulator withdraws Amgen's Tavneos authorization over serious trial breachesEuropean regulators have withdrawn the marketing authorization for Amgen's rare disease drug Tavneos, citing serious breaches in the pivotal clinical trial. The EMA said study staff from ChemoCent…